In contrast to MS, however, a secondary progressive disease course is extremely rare in both AQP4-IgG+NMOSD and MOGAD and should prompt considering alternative etiologies (see also “Atypical clinical-MRI phenotypes and risk of false positivity” below) (100). This evidence concerns the gene AQP4 and myeloid sarcoma.